JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mueller, R. A.
Right arrow Articles by Shideman, F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mueller, R. A.
Right arrow Articles by Shideman, F. E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 160, Issue 1, 53-60, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


RESTORATION OF CARDIAC RESPONSIVENESS TO TYRAMINE AFTER RESERPINE

Robert A. Mueller 1 and F. E. Shideman 1

1 Department of Pharmacology, College of Medical Sciences, University of Minnesota, Minneapolis, Minnesota

The return of responsiveness of isolated perfused cat hearts to tyramine was determined at several intervals after pretreatment with reserpine in vivo. At 9 days but not at 7 days after reserpine the magnitude of the increase in coronary flow and in heart rate produced by tyramine was equal to that of control hearts. Although endogenous norepinephrine (NE) levels were still significantly depressed at 9 days after reserpine, the percentage of NE present in the soluble fraction of ventricular homogenates was greater than in control hearts, yet the concentration of NE in this fraction was still significantly less than normal. Tracer doses of dl-7-H3-norepinephrine (H3-NE) were taken up and retained normally in hearts 9 days after reserpine, but not at 7 days, although the subcellular distribution of H3-NE at both 7 and 9 days after reserpine administration was not significantly different from that of control hearts. The capacity of tyramine to release cardiac H3-NE in vitro had returned to normal at 9 days, but was still significantly depressed at 7 days after reserpine. There was no alteration in the rate of release of H3-NE or its O-methylated metabolites during control perfusion time periods. The results indicate that the return of normal cardiac responsiveness to tyramine in vitro correlates most closely with the capacity of the heart to store H3-NE in vivo and to release H3-NE in vitro. These results support the view that the neurotransmitter store of NE concerned with the sympathomimetic response to tyramine represents only a small fraction of the total NE stores.

Submitted on May 29, 1967
Accepted on November 14, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.